EAM
IMMU

EverPoint Asset Management’s Immunomedics Inc IMMU Stock Holding History

EverPoint Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$12.2M Buy
+3,335,000
New +$9.87M 0.23% 121

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

EverPoint Asset Management's IMMU Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Immunomedics Inc (IMMU) in Q4 2016: 3,335,000 shares worth $12.2M. The stake represents 0.23% of the portfolio and ranks #121 among its holdings.

109 funds tracked by Wall St. Rank hold IMMU as of Q4 2016.

  • EverPoint Asset Management held 3,335,000 shares of Immunomedics Inc worth $12.2M as of Q4 2016.
  • Immunomedics Inc was a new EverPoint Asset Management position in Q4 2016.
  • Immunomedics Inc made up 0.23% of EverPoint Asset Management's portfolio in Q4 2016, its #121 holding.
  • 109 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.